In Vitro assessment of clarithromycin and erythromycin depletion in the presence of andrographolide using human liver microsomes
Frontiers in Pharmacology · 02.11.2026 · 17
DOI: 10.3389/fphar.2026.1983947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.11.2026. Verfasst von Phornpimon Tipthara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Andrographolide is a major bioactive compound of Andrographis paniculata , a medicinal herb widely used in Asia. Previous in vitro studies have reported effects of andrographolide on CYP3A4 expression and activity. However, potential pharmacokinetic interactions with the macrolide antibiotics clarithromycin and erythromycin remain poorly characterized. This study investigated the effect of andrographolide on their in vitro depletion using pooled human liver microsomes (HLMs).
Methods
Clarithromycin and erythromycin (1 µM each) were incubated in pooled HLMs with or without andrographolide at 2, 10, or 20 μM, corresponding to approximately 10-, 50-, and 100-fold the reported peak concentration (C max ), respectively. Parent-antibiotic depletion was monitored by LC-MS/MS, and depletion rates were estimated by linear regression.
Results
Andrographolide did not significantly alter clarithromycin depletion at two or 10 µM ( p = 0.1906 and 0.7898), whereas a significant difference was observed at 20 µM ( p = 0.0321). The estimated effects had wide 95% confidence intervals. Erythromycin depletion was significantly altered at all concentrations, with relative differences of 38.5% (95% CI, 28.5%–48.5%), 33.5% (28.6%–38.3%), and 66.2% (57.0%–75.5%) at 2, 10, and 20 μM, respectively (all p < 0.0001).
Conclusion
Andrographolide exerts a strong, concentration-dependent effect on in vitro erythromycin depletion in HLMs, whereas its effect on clarithromycin depletion is minimal and observed only at supra-therapeutic concentrations (100-fold C max ). Given that effective concentrations exceeded physiological C max levels, clinical relevance remains uncertain. Further investigation is needed to clarify underlying metabolic mechanisms and evaluate in vivo translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
- Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Tipthara, P., Apinan, S., Kullasakboonsri, R., Sueksakit, K., Reamtong, O., & Tarning, J. (2026). In Vitro assessment of clarithromycin and erythromycin depletion in the presence of andrographolide using human liver microsomes. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1983947
Vancouver
Tipthara P, Apinan S, Kullasakboonsri R, Sueksakit K, Reamtong O, Tarning J. In Vitro assessment of clarithromycin and erythromycin depletion in the presence of andrographolide using human liver microsomes. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1983947
BibTeX
@article{Tipthara2026,
author = {Tipthara, Phornpimon and Apinan, Siribha and Kullasakboonsri, Rattawan and Sueksakit, Kanyarat and Reamtong, Onrapak and Tarning, Joel},
title = {In Vitro assessment of clarithromycin and erythromycin depletion in the presence of andrographolide using human liver microsomes},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1983947}
}
EUVIMED